COMMUNIQUÉS West-GlobeNewswire

Novartis JULIET trial of Kymriah demonstrates more than one-year durability of responses in adults with relapsed or refractory DLBCL

16/06/2018 - 11:31

Overall response rate was 52% and median duration of response was not reached at a median follow-up of 14 months, signifying responses were durable[1] Patients had a 65% chance of being relapse-free one year after onset [...]

Alberta Business Community Raises $640,000 for 2018 CEO Rescue in the Rockies for STARS Fundraiser

16/06/2018 - 05:00

CEOs “rescued” from mountaintop after achieving fundraising goals and completing survival challenges CALGARY, Alberta, June 15, 2018 (GLOBE NEWSWIRE) -- The Shock Trauma Air Rescue Service (STARS) is pleased to announce [...]

Precipio Inc. Announces Adjournment of Annual Meeting of Shareholders

16/06/2018 - 02:11

NEW HAVEN, Conn., June 15, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announced today that the Company’s 2018 Annual Meeting of Shareholders, originally scheduled for 9:30 a.m [...]

Alder BioPharmaceuticals® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

15/06/2018 - 23:00

BOTHELL, Wash., June 15, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (Nasdaq:ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]

Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)

15/06/2018 - 22:05

RADNOR, Pa., June 15, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”, “Marinus”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat [...]

ObsEva SA to Hold Investor Call to Announce Topline Results of the EDELWEISS Phase 2b Clinical Trial of Linzagolix (OBE2109) in Women with Endometriosis-Associated Pain on Monday June 18, 2018

15/06/2018 - 22:00

Geneva, Switzerland and Boston, MA - June 15, 2018 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions [...]

Kalytera Announces Second Payments Agreement with The Salzman Group of Israel

15/06/2018 - 20:55

SAN FRANCISCO and TEL AVIV, Israel, June 15, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE:KALY) (OTCQB:KALTF) (the " Company " or " Kalytera ") today announced that it has entered into an agreement [...]

Optinose CEO Peter Miller and President and COO Ramy Mahmoud Named EY Life Sciences Entrepreneur Of The Year 2018 in Greater

15/06/2018 - 20:05

YARDLEY, Pa., June 15, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that CEO Peter Miller [...]

Immunomedics Announces Closing of Public Offering of Common Stock

15/06/2018 - 17:39

MORRIS PLAINS, N.J., June 15, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ:IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today [...]

Grant of Warrants

15/06/2018 - 17:32

June 15, 2018 Announcement no. 11 In accordance with the company's guidelines relating to incentive remuneration and the authorization in Section 18 of the Articles of Association, the Board of Directors of BioPorto A/S [...]

Nohla Announces Presentation of Dilanubicel (NLA101) Data at EHA Annual Meeting Showcasing Excellent Long-term Survival Outcomes

15/06/2018 - 17:30

Compelling Evidence of Rapid Immune Recovery and Improved Long-Term Outcomes After Hematopoietic Stem Cell Transplant SEATTLE, June 15, 2018 (GLOBE NEWSWIRE) -- Nohla Therapeutics, a leading developer of universal, off- [...]

Hemispherx Releases First 8,500 Vial Lot of Ampligen to Supply Expanded Access Programs in the United States, Europe and Canada for ME/CFS and Pancreatic Cancer and Announces Successful Finish of Second Commercial Size Lot

15/06/2018 - 16:19

Balance for New Cancer Clinical Trials; Second Commercial-Size Batch Now in Regulatory Testing ORLANDO, Fla., June 15, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB) has announced the successful [...]

Analogic Introduces Its Newest RF Amplifier for 1.5 Tesla MRI Systems

15/06/2018 - 16:00

PEABODY, Mass., June 15, 2018 (GLOBE NEWSWIRE) -- Analogic Corporation (Nasdaq:ALOG), enabling the world’s medical imaging and aviation security technology, has announced the release of the AN8150-01 1.5T 20 kW RF [...]

Sienna Announces June Dividend

15/06/2018 - 16:00

MARKHAM, Ontario, June 15, 2018 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX:SIA) today announced a dividend of $0.075 per common share of the Company (each, a “Common Share”) for [...]

TG Therapeutics, Inc. Announces Clinical and Preclinical Data Presentations at the 23rd Congress of the European Hematology Association

15/06/2018 - 15:17

NEW YORK, June 15, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX), today announced the presentation of an integrated analysis of long term safety data of umbralisib (TGR-1202), the Company’s PI3K delta [...]

Polydex Pharmaceuticals Issues First Quarter Financial Results

15/06/2018 - 15:15

Continued Profitability and Increased Unit Sales in U.S. TORONTO, June 15, 2018 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (Pink Sheets:POLXF) (the “Company”) reports financial results for the first quarter of [...]

CV Sciences, Inc. Announces Landmark Publication on the Toxicology and Safety Assessment of Base Material of its PlusCBD Oil™ Products

15/06/2018 - 14:45

LAS VEGAS, June 15, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”) announced today the June 7, 2018 publication of the toxicology and safety results of an extract [...]

Medtronic Receives FDA Approval for 200mm & 250mm IN.PACT(TM) Admiral(TM) Drug Coated Balloons

15/06/2018 - 14:31

New, Extended Balloon Lengths Enable Physicians to Efficiently Treat Long SFA Lesions DUBLIN - June 15, 2018 - Medtronic plc (NYSE: MDT) today announced that it has received U.S. Food and Drug Administration (FDA) [...]

Stemline Therapeutics Announces Presentation of ELZONRIS™ (tagraxofusp; SL-401) Preclinical Data in Systemic Sclerosis, an Autoimmune Disorder, at EULAR Congress

15/06/2018 - 14:15

NEW YORK, June 15, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, announced today that ELZONRIS™ (tagraxofusp; SL- [...]